Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $149.1100 (0.59%) ($147.1600 - $149.7500) on Mon. Oct. 9, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.12% (three month average) | RSI | 32 | Latest Price | $149.1100(0.59%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.1% a day on average for past five trading days. | Weekly Trend | ABBV declines -1.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) DIA(55%) IBB(54%) VYM(51%) SPLV(50%) | Factors Impacting ABBV price | ABBV will decline at least -0.56% in a week (0% probabilities). VXX(-37%) VIXM(-34%) USO(-25%) EDOC(-25%) TBT(-24%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.56% (StdDev 1.12%) | Hourly BBV | 1.2 () | Intraday Trend | 0.7% | | | |
|
Resistance Level | $151.13 | 5 Day Moving Average | $147.98(0.76%) | 10 Day Moving Average | $149.54(-0.29%) | 20 Day Moving Average | $151.13(-1.34%) | To recent high | -3.6% | To recent low | 11.6% | Market Cap | $263.072b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |